demonstrated that mice fibrosis model and patients with IPF and nonalcoholic steatohepatitis (NASH) had high levels of RSPO3, suggesting that RSPO3 might induce the secretion of fibrogenic chemokines and cytokines in the lung and hepatocytes [74]. The gene discussed is RSPO3; the disease is metabolic dysfunction-associated steatohepatitis.